ID: ALA2153647

Max Phase: Preclinical

Molecular Formula: C28H34N6O7

Molecular Weight: 566.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O)OCc1ccc(C(=O)O)cc1

Standard InChI:  InChI=1S/C28H34N6O7/c35-24(10-9-23(26(38)39)32-28(40)41-18-19-5-7-20(8-6-19)25(36)37)34-15-13-33(14-16-34)22-4-1-3-21(17-22)31-27-29-11-2-12-30-27/h1,3-8,17,23H,2,9-16,18H2,(H,32,40)(H,36,37)(H,38,39)(H2,29,30,31)/t23-/m0/s1

Standard InChI Key:  MRXQBHPWVQTUKZ-QHCPKHFHSA-N

Associated Targets(Human)

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-5 589 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 566.62Molecular Weight (Monoisotopic): 566.2489AlogP: 1.95#Rotatable Bonds: 10
Polar Surface Area: 172.90Molecular Species: ZWITTERIONHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.43CX Basic pKa: 9.97CX LogP: -0.34CX LogD: -3.10
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.29Np Likeness Score: -0.79

References

1. Alloatti D, Giannini G, Vesci L, Castorina M, Pisano C, Badaloni E, Cabri W..  (2012)  Camptothecins in tumor homing via an RGD sequence mimetic.,  22  (20): [PMID:22959246] [10.1016/j.bmcl.2012.07.061]

Source